Intrapulmonary Penetration of Sitafloxacin and Treatment Outcomes in Thai Critically Ill Patients with Pneumonia
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2019
Price : $35 *
At a glance
- Drugs Sitafloxacin (Primary)
- Indications Nosocomial pneumonia; Pneumonia; Respiratory insufficiency
- Focus Pharmacokinetics; Therapeutic Use
- 06 Nov 2018 Status changed from recruiting to discontinued.
- 08 Feb 2018 Status changed from not yet recruiting to recruiting.
- 05 Jun 2017 New trial record